The company will use the new capital to support its growth, expand its technology platform, and accelerate its global expansion efforts--further strengthening its ability to help sponsors execute decentralized trials and enable patients to participate in trials from anywhere, without traveling to a traditional clinical site.

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

12121 Bluff Creek Dr. 100
Los Angeles, CA 90094
USA

Phone

(984) 377-3737

Website

www.science37.com

Email Address

[email protected]

Overview

At Science 37, we don't see diseases, we see people -- the patients who are suffering and the physician-scientists trying to help. S37 was created to help patients access the most advanced research available to help with their health problems.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Coman

Chief Financial Officer

Michael Zaranek

Chief Medical Officer

Jonathan Cotliar

Vice President

Jonathan Commons

Vice President

Darcy Forman

VP - Administration

Adriana Centeno

VP - Bus. Development

Steve Geffon

VP - General Counsel

Laura Podolsky

VP - Product Management

Chris Ceppi

Browse more venture capital transactions:

Prev: 8/21/2020: Lootcakes venture capital transaction
Next: 8/25/2020: Shef venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary